Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true?
Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects.
The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings?
A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.
##https://athenacool.wordpress.com/2019/05/21/bottle-of-lies/
評分##闊怕 保命請認準大廠原研藥 以及第三世界真實從頭慘到腳
評分##Generic drugs still have a long way to go
評分##問題本身並不僅限於藥企,本質上是policymaker和lawmaker如何能改良現有框架適應全球化,要不然遲早是下一個羅馬。
評分##一個這麼好的題材,被作者寫得稀爛。故事非常散亂且冗長。有種所有我調查到的內容都要填進去的雜亂感。人物臉譜化,凡正麵角色一定要講到成長經曆,父親職業的影響,反麵角色一定是生活奢迷,草菅人命,毫無道德可言。350字裝不下我的吐槽。可能需要寫一篇長評。。。。。。
評分##an astonishing scandal involving people desperate for cheap drugs, "meaningless" efforts made by individuals, "evil" companies, historically do-nothing FDA, politics and poor regulations. yet sadly the same story will happen again and again and again.
評分##優點是:1 故事精彩,特彆是Ranbaxy部分 2 對仿製藥的齣現和問題的支齣,在4+7時代尤其重要。缺點是:1 太多采訪驅動,數據太少,導緻麵子太多裏子不夠 2 野心太大導緻主綫太散
評分##讀瞭三分之二終究還是決定放棄瞭????一個理科生隻想看是啥原理導緻仿製藥的巨大問題,卻不太想知道中間那麼多復雜而又牽扯巨多的故事細節????????????然鵝這本書連uplcms都要解釋一下但沒解釋清楚。。。
評分觸目驚心,我國石傢莊一傢藥企“上榜”,生産的無效頭孢在非洲緻兒童死亡,中文版裏不知能否保留
本站所有內容均為互聯網搜尋引擎提供的公開搜索信息,本站不存儲任何數據與內容,任何內容與數據均與本站無關,如有需要請聯繫相關搜索引擎包括但不限於百度,google,bing,sogou 等
© 2026 book.teaonline.club All Rights Reserved. 圖書大百科 版權所有